BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16434379)

  • 1. Radioimmunotherapy and autologous stem cell transplantation for the treatment of B-cell lymphomas.
    Cilley J; Winter JN
    Haematologica; 2006 Jan; 91(1):114-20. PubMed ID: 16434379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunotherapeutic strategies in autologous hematopoietic stem-cell transplantation for malignant lymphoma.
    Inwards DJ; Cilley JC; Winter JN
    Best Pract Res Clin Haematol; 2006; 19(4):669-84. PubMed ID: 16997176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B.
    Nademanee A; Forman SJ
    Semin Hematol; 2006 Oct; 43(4):240-50. PubMed ID: 17027658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunotherapy and Autologous Stem-Cell Transplantation in the Treatment of B-Cell Non-Hodgkin Lymphoma.
    Shimoni A; Zwas ST
    Semin Nucl Med; 2016 Mar; 46(2):119-25. PubMed ID: 26897716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High-dose chemotherapy with autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in complete response as consolidation therapy, second report].
    Yamane T; Hirose A; Nakajima Y; Nakane T; Koh H; Takeoka Y; Nakamae M; Yamamura R; Nakamae H; Nakao Y; Mugitani A; Yagi T; Teshima H; Hino M
    Gan To Kagaku Ryoho; 2006 Feb; 33(2):193-8. PubMed ID: 16484855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunotherapy for B-cell non-Hodgkin lymphoma.
    Nowakowski GS; Witzig TE
    Clin Adv Hematol Oncol; 2006 Mar; 4(3):225-31. PubMed ID: 16728934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy.
    Espigado I; Ríos E; Marín-Niebla A; Carmona M; Parody R; Pérez-Hurtado JM; Márquez FJ; Urbano-Ispizua A
    Transplant Proc; 2008 Nov; 40(9):3104-5. PubMed ID: 19010208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunotherapy for treatment of B-cell lymphomas and other hematologic malignancies.
    Park SI; Press OW
    Curr Opin Hematol; 2007 Nov; 14(6):632-8. PubMed ID: 17898567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous hematopoietic stem cell transplant in first remission in non-Hodgkin's lymphoma.
    Tomblyn M; Winter JN
    Expert Rev Anticancer Ther; 2003 Jun; 3(3):281-94. PubMed ID: 12820773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen.
    Smith SD; Bolwell BJ; Rybicki LA; Brown S; Dean R; Kalaycio M; Sobecks R; Andresen S; Hsi ED; Pohlman B; Sweetenham JW
    Bone Marrow Transplant; 2007 Aug; 40(3):239-43. PubMed ID: 17530000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunotherapy and stem-cell transplantation in the treatment of aggressive B-cell lymphoma.
    Shimoni A; Nagler A
    Leuk Lymphoma; 2007 Nov; 48(11):2110-20. PubMed ID: 17891639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of radioimmunoconjugates in stem cell transplantation.
    Pagel JM; Matthews DC; Appelbaum FR; Bernstein ID; Press OW
    Bone Marrow Transplant; 2002 May; 29(10):807-16. PubMed ID: 12058230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
    Zhou Y; Zhang L; Romaguera J; Delasalle K; Han X; Du X; Kwak L; Yi Q; Wang M
    Am J Hematol; 2008 Feb; 83(2):144-9. PubMed ID: 17722077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.
    Costa LJ; Micallef IN; Inwards DJ; Johnston PB; Porrata LF; Litzow MR; Ansell SM
    Br J Haematol; 2008 Oct; 143(2):268-73. PubMed ID: 18699848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of rituximab on the long-term outcome after high-dose therapy for relapsed B-cell non-Hodgkin's lymphoma.
    Hess G; Flohr T; Kolbe K; Bonn S; Schuler M; Derigs HG; Huber C
    Ann Hematol; 2006 Nov; 85(11):769-79. PubMed ID: 16896912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma: a single-centre study of 20 patients.
    Aydin S; Dührsen U; Nückel H
    Ann Hematol; 2007 Apr; 86(4):271-6. PubMed ID: 17216473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell transplantation in the treatment of peripheral T-cell lymphomas.
    Majhail NS; Burns LJ
    Curr Hematol Rep; 2005 Jul; 4(4):252-9. PubMed ID: 16009039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of hematopoietic stem cell transplantation after treatment with different high-dose total-body irradiation regimens in five Dutch centers.
    van Kempen-Harteveld ML; Brand R; Kal HB; Verdonck LF; Hofman P; Schattenberg AV; van der Maazen RW; Cornelissen JJ; Eijkenboom WM; van der Lelie JP; Oldenburger F; Barge RM; van Biezen A; Vossen JM; Noordijk EM; Struikmans H
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1444-54. PubMed ID: 18294781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
    Huang H; Cai Q; Lin T; Lin X; Liu Y; Gao Y; Peng R
    Expert Opin Pharmacother; 2009 Oct; 10(15):2399-406. PubMed ID: 19761353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.